Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
4
×
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
bristol-myers squibb
celgene
deals
intercept pharmaceuticals
startups
2019
4d molecular therapeutics
abbvie
acne
activism
acute hepatic porphyria
agenus
What
disease
4
×
drug
4
×
bio
liver
race
roundup
adds
advanced
alliance
alnylam’s
alzheimer's
approval
approved
areas
bad
bff
biosciences
bio’s
brain
brii
cancer
case
companies
conference
deals
devoted
digital
doses
earlier
easl
epidemic
failed
fatty
fda
fight
form
fortune
frenzied
gene
goes
Language
Current search:
disease
×
drug
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline